Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Targeting the B7 Family of Co-Stimulatory Molecules : Successes and Challenges.
Modeling the acute and chronic phases of Theiler murine encephalomyelitis virus (TMEV) infection.
Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings.
SNPsea: an algorithm to identify cell types, tissues, and pathways affected by risk loci.
IL-15-secreting γδT cells induce memory T cells in experimental allergic encephalomyelitis (EAE) mice.
Optic neuritis following aseptic meningitis associated with modified measles: a case report.
Podoplanin negatively regulates CD4+ effector T cell responses.
Increased incidence of multiple sclerosis in systemic sclerosis: A nationwide cohort study.
Comparative study of the efficacy of limaprost and pregabalin as single agents and in combination for the treatment of lumbar spinal stenosis: a prospective, double blind, randomized controlled non-inferiority trial.
Tumefactive multiple sclerosis and fingolimod: Immunotherapies and unintended consequences.
Requirement of CD30 expression on CD4 T cells in the pathogenesis of experimental autoimmune encephalomyelitis.
Medications Are Associated with Falls in People with Multiple Sclerosis: A Prospective Cohort Study.
Salvianolic acid B ameliorates CNS autoimmunity by suppressing Th1 responses.
Clinical Outcome of 50 Progressive Multiple Sclerosis Patients Treated with Cellular Therapy in Iraq.
Higher expression of IL-12Rβ2 is associated with lower risk of relapse in relapsing-remitting multiple sclerosis patients on interferon-β1b therapy during 3-year follow-up.
Progressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice.
Epidemiology of multiple sclerosis in Qom: Demographic study in Iran.
Cognitive and Affective Assessments of Multiple Sclerosis (MS) and Neuromyelitis Optica (NMO) Patients Utilizing Computerized Touch Panel-type Screening Tests.
Oral therapy approved for multiple sclerosis.
[Epidemiological characteristics of multiple sclerosis in the Kabardino-Balkaria Republic.]
Natalizumab SC Similar to IV Every 4 Weeks for MS
Fluoxetine in Progressive Multiple Sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial.
Quantitative MRI of the spinal cord and brain in adrenomyeloneuropathy: in vivo assessment of structural changes.
Brain functional plasticity at rest and during action in multiple sclerosis patients.
Long-term safety and efficacy of natalizumab in relapsing-remitting multiple sclerosis: impact on quality of life.

Pages